Breast cancer patient featured in The Cancer Letter receives testing for COVID-19, awaits results

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Last week, The Cancer Letter spoke with Janice Cowden, a patient with metastatic breast cancer and symptoms of COVID-19—who was denied testing despite being especially vulnerable to the disease (The Cancer Letter, March 20).

Cowden has since received two tests for COVID-19—a nasopharyngeal swab at a curbside clinic, and a throat pharyngeal swab at the office of her primary care physician. She has yet to receive the results of either test.

Prior to developing symptoms, Cowden had attended a fundraiser with about 300 people—including dozens of women with metastatic breast cancer.

Table of Contents

YOU MAY BE INTERESTED IN

As NCI and NIH funding is being deliberated in Congress, this year’s 2025 AACR Cancer Progress Report had an unequivocal message: With 20 new anticancer therapeutics, new uses for eight previously approved anticancer therapeutics, two new early detection tools, and several AI-powered diagnostics approved over the span of just one year, cancer research funding yields a good return on investment. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login